Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rallybio Corporaton (RLYB)

Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rallybio Corporaton 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 USA

www.rallybio.com Employees: 25 P: 203-859-3820

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 31,903
Enterprise Value, $K 18,003
Shares Outstanding, K 42,244
Annual Sales, $ 640 K
Annual Net Income, $ -57,780 K
Last Quarter Sales, $ 210 K
Last Quarter Net Income, $ 16,020 K
EBIT, $ -38,270 K
EBITDA, $ -39,750 K
60-Month Beta -1.05
% of Insider Shareholders 8.70%
% of Institutional Shareholders 90.34%
Float, K 38,569
% Float 91.30%
Short Interest 140
Short Float 0.33%
Short Volume Ratio 0.11

Growth:

1-Year Return -14.64%
3-Year Return -88.51%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/06/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr 36.36%
EPS Growth vs. Prev Year 46.15%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RLYB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.23%
Return-on-Assets % -59.90%
Profit Margin % -9,028.13%
Debt/Equity 0.00
Price/Sales 52.04
Price/Cash Flow N/A
Price/Book 0.52
Book Value/Share 1.51
Interest Coverage -1.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar